KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Cost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Cme (CME) Shares Outstanding (2016 - 2026)

Cme has reported Shares Outstanding over the past 18 years, most recently at $361.8 million for Q1 2026.

  • Quarterly Shares Outstanding rose 12059566.67% to $361.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $361.8 million through Mar 2026, up 12059566.67% year-over-year, with the annual reading at $4.6 million for FY2025, 0.0% changed from the prior year.
  • Shares Outstanding was $361.8 million for Q1 2026 at Cme, up from $359.0 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $361.8 million in Q1 2026 and troughed at $3000.0 in Q1 2023.
  • The 5-year median for Shares Outstanding is $359.0 million (2025), against an average of $275.4 million.
  • Biggest five-year swings in Shares Outstanding: plummeted 100.0% in 2024 and later surged 12059566.67% in 2026.
  • Tracing CME's Shares Outstanding over 5 years: stood at $4.6 million in 2022, then skyrocketed by 7736.63% to $359.2 million in 2023, then tumbled by 98.72% to $4.6 million in 2024, then changed by 0.0% to $4.6 million in 2025, then surged by 7792.45% to $361.8 million in 2026.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $361.8 million, $4.6 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.